Research ArticleCancer

Clinical impact of the NKp30/B7-H6 axis in high-risk neuroblastoma patients

See allHide authors and affiliations

Science Translational Medicine  15 Apr 2015:
Vol. 7, Issue 283, pp. 283ra55
DOI: 10.1126/scitranslmed.aaa2327

Article Information

vol. 7 no. 283 283ra55

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication November 4, 2014
  • Accepted for publication February 24, 2015
  • .

Author Information

  1. Michaela Semeraro1,2,3,4,5,6,*,
  2. Sylvie Rusakiewicz1,2,7,*,
  3. Véronique Minard-Colin1,2,3,
  4. Nicolas F. Delahaye1,2,
  5. David Enot1,5,6,
  6. Frédéric Vély8,9,10,11,
  7. Aurélien Marabelle12,
  8. Benjamin Papoular1,2,
  9. Christelle Piperoglou11,
  10. Mirco Ponzoni13,
  11. Patrizia Perri13,
  12. Andrei Tchirkov14,15,
  13. Jessica Matta8,9,10,
  14. Valérie Lapierre1,16,
  15. Tala Shekarian12,
  16. Sandrine Valsesia-Wittmann12,
  17. Frédéric Commo1,2,
  18. Nicole Prada1,2,
  19. Vichnou Poirier-Colame1,2,
  20. Brigitte Bressac17,
  21. Sophie Cotteret1,2,
  22. Laurence Brugieres1,3,
  23. Françoise Farace1,18,
  24. Nathalie Chaput1,2,7,
  25. Guido Kroemer1,5,6,19,20,,
  26. Dominique Valteau-Couanet1,2,3, and
  27. Laurence Zitvogel1,2,4,7,,
  1. 1Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France.
  2. 2INSERM U1015, GRCC, 94805 Villejuif, France.
  3. 3Department of Pediatric Oncology, GRCC, 94805 Villejuif, France.
  4. 4University of Paris Sud XI, 94805 Villejuif, France.
  5. 5Equipe 11 labelisée par la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, 75006 Paris, France.
  6. 6INSERM U1138, 94805 Villejuif, France.
  7. 7Center of Clinical Investigations in Biotherapies of Cancer, CICBT507, GRCC, 94805 Villejuif, France.
  8. 8Centre d’Immunologie de Marseille-Luminy, INSERM, U1104, F-13009 Marseille, France.
  9. 9CNRS, UMR7280, F-13009 Marseille, France.
  10. 10Aix Marseille Université, UM2, F-13009 Marseille, France.
  11. 11Service d’Immunologie, Assistance Publique–Hôpitaux de Marseille, Hôpital de la Conception, F-13009 Marseille, France.
  12. 12Centre de Recherche en Cancérologie de Lyon, UMR INSERM U1052 CNRS 5286, Centre Léon Bérard, Université de Lyon, 69000 Lyon, France.
  13. 13Giannina Gaslini Hospital, Experimental Therapy Unit Laboratory of Oncology, 16147 Genoa, Italy.
  14. 14EA 4677 ERTICa, CHU et Centre Jean Perrin, 63011 Clermont-Ferrand, France.
  15. 15CHU de Clermont-Ferrand, Service de Cytogénétique Médicale, Hôpital Estaing, 63001 Clermont-Ferrand, France.
  16. 16Cell Therapy Unit, GRCC, 94805 Villejuif, France.
  17. 17Service de Génétique, Molecular Genetic Department, GRCC, 94805 Villejuif, France.
  18. 18INSERM U981, 94805 Villejuif, France.
  19. 19University of Paris Descartes/ParisV, Sorbonne Paris Cité, 75005 Paris, France.
  20. 20Pôle de Biologie, Hôpital Européen Georges Pompidou, 75015 Paris, France.
  1. Corresponding author. E-mail: laurence.zitvogel{at}gustaveroussy.fr (L.Z.); kroemer{at}orange.fr (G.K.)
  • * These authors contributed equally to this work.

  • These authors contributed equally to this work.

Altmetric

Article usage

Article usage: April 2015 to August 2019

AbstractFullPdf
Apr 20154819180296
May 201584623103
Jun 20153331572
Jul 20151432380
Aug 2015651750
Sep 201555842
Oct 201535476
Nov 201544766
Dec 201544857
Jan 20161251337
Feb 20161071323
Mar 2016841119
Apr 201680117
May 201694917
Jun 20161381021
Jul 20168085
Aug 2016911112
Sep 20161421010
Oct 20161071911
Nov 2016991115
Dec 2016771112
Jan 20175889
Feb 2017951718
Mar 201711359
Apr 20179046
May 201760916
Jun 20175748
Jul 201795814
Aug 2017911116
Sep 20178259
Oct 20179449
Nov 201792910
Dec 20175647
Jan 20186248
Feb 20187433
Mar 2018103511
Apr 20189365
May 2018168912
Jun 201881313
Jul 20186955
Aug 201825213
Sep 2018511510
Oct 2018831312
Nov 201891127
Dec 201811282
Jan 201980169
Feb 201963126
Mar 20195145
Apr 20192223
May 201932117
Jun 201924136
Jul 20192644
Aug 20199115